🇺🇸 FDA
Patent

US 7473525

Compositions and methods for inhibiting expression of anti-apoptotic genes

granted A61PA61P1/18A61P35/00

Quick answer

US patent 7473525 (Compositions and methods for inhibiting expression of anti-apoptotic genes) held by Alnylam Europe AG expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Europe AG
Grant date
Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/18, A61P35/00